Conferences

SNMMI 2021: CT and MRI Appearances of Adrenal Lesions July 20, 2021

SNMMI 2021: CT and MRI Appearances of Benign and Malignant Lesions in Prostate Cancer July 20, 2021

SNMMI 2021: Characterizing Bone Lesions in Prostate Cancer Patients with PET/CT Imaging July 20, 2021

EAU 2021: Apalutamide for Metastatic Castration-Sensitive Prostate Cancer: Outcomes in High-Volume and Low-Volume Disease From the TITAN Final Analysis July 14, 2021

EAU 2021: Time on Treatment with Abiraterone and Enzalutamide in the Patient-Overview Prostate Cancer in the National Prostate Cancer Register of Sweden July 14, 2021

EAU 2021: Treatment Options for De-Novo mHSPC: Future: Personalized Medicine for mHSPC? July 14, 2021

EAU 2021: Impact of Prior Local Therapy on Survival in mCRPC: Results from COU-AA-302 Trial July 14, 2021

EAU 2021: Treatment Options for De-Novo mHSPC: Local Treatment: Surgery (Primary +/- Lymph Nodes) July 14, 2021

EAU 2021: Treatment Options for De-Novo mHSPC: Systemic Treatments: How to Choose the Right Treatment for the Right Patient July 14, 2021

EAU 2021: Treatment Options for De-Novo mHSPC: Local Treatment: Radiation Therapy (Primary +/- Lymph Nodes) July 14, 2021

EAU 2021: Identification of the Best Candidates for PSMA PET/CT Among Patients Experiencing Biochemical Recurrence After Radical Prostatectomy: A New Tool to Optimize of Patient Selection July 14, 2021

EAU 2021: Gaps in the Evidence: Adjuvant Versus Early Salvage Radiotherapy July 14, 2021

EAU 2021: Gaps in the Evidence: Optimal Treatment for cN1 Patients July 14, 2021

EAU 2021: Intraprostatic Recurrences on PSMA PET/CT After Prostate Whole Gland Radiotherapy: Is Histological Confirmation Necessary? July 14, 2021

EAU 2021: Long-Term Validation on the Impact of PSMA-PET on Metastasis-Free Survival in a Large Salvage Radiotherapy Cohort July 14, 2021

EAU 2021: Should We Perform PSMA PET/CT in the Initial Staging of Prostate Cancer? A Pro Versus Con Debate July 14, 2021

EAU 2021: Preoperative PSMA PET/CT as a Predictor of Biochemical Persistence and Early Biochemical Recurrence July 14, 2021

EAU 2021: Association of Local Progression with Deterioration of Urinary Symptoms and Occurrence of Genitourinary Adverse Events (AEs) in Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): Post Hoc Analysis of PROSPER July 14, 2021

EAU 2021: Evolving Landscape of First-Line Systemic Treatment in Metastatic Renal Cell Carcinoma July 13, 2021

EAU 2021: Predicting Early Biochemical Progression in Prostate Cancer Patients Staged with PSMA PET and Multiparametric Magnetic Resonance Imaging July 13, 2021

Page 1 of 411